Publicaciones en colaboración con investigadores/as de Hospital Virgen del Camino (5)

2021

  1. Pembrolizumab plus eribulin in hormone-receptor–positive, HER2-negative, locally recurrent or metastatic breast cancer (KELLY): An open-label, multicentre, single-arm, phase Ⅱ trial

    European Journal of Cancer, Vol. 148, pp. 382-394

2019

  1. Phase II, Multicenter, Single-arm Trial of Eribulin as First-line Therapy for Patients With Aggressive Taxane-pretreated HER2-Negative Metastatic Breast Cancer: The MERIBEL Study

    Clinical Breast Cancer, Vol. 19, Núm. 2, pp. 105-112

2017

  1. Role of total tumour load of sentinel lymph node on survival in early breast cancer patients

    Breast, Vol. 33, pp. 8-13

2013

  1. Neuralgiadel trigémino: Radiofrecuencia ganglio de Gasser

    Revista de la Sociedad Espanola del Dolor, Vol. 20, Núm. 2, pp. 89-100

2010

  1. Editorial: Whither thou goest pain?

    Revista de la Sociedad Espanola del Dolor, Vol. 17, Núm. 4, pp. 187-189